BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dewas S, Bibault JE, Mirabel X, Fumagalli I, Kramar A, Jarraya H, Lacornerie T, Dewas-Vautravers C, Lartigau E. Prognostic factors affecting local control of hepatic tumors treated by Stereotactic Body Radiation Therapy. Radiat Oncol. 2012;7:166. [PMID: 23050794 DOI: 10.1186/1748-717x-7-166] [Cited by in Crossref: 46] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Zhu J, Zhang HJ, Zhang XQ, Ju XP, Lu MZ, Liu YM, Cao YS, Yu CS, Wang XY. Short-term effects of cyberknife combined with TACE for treatment of primary liver cancer. Shijie Huaren Xiaohua Zazhi 2014; 22(14): 2039-2044 [DOI: 10.11569/wcjd.v22.i14.2039] [Reference Citation Analysis]
2 Kurosu K, Sumida I, Suzuki O, Shiomi H, Ota S, Otani K, Tamari K, Seo Y, Ogawa K. Dosimetric and clinical effects of interfraction and intrafraction correlation errors during marker-based real-time tumor tracking for liver SBRT. J Radiat Res 2018;59:164-72. [PMID: 29253275 DOI: 10.1093/jrr/rrx067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Harada Y, Miyazaki S. CyberKnife Stereotactic Radiosurgery for Cholangiocarcinoma. Intern Med 2018;57:1411-4. [PMID: 29279492 DOI: 10.2169/internalmedicine.9572-17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Shen ZT, Zhou H, Li AM, Li B, Shen JS, Zhu XX. Clinical outcomes and prognostic factors of stereotactic body radiation therapy for intrahepatic cholangiocarcinoma. Oncotarget. 2017;8:93541-93550. [PMID: 29212171 DOI: 10.18632/oncotarget.19972] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
5 Habermehl D, Herfarth KK, Bermejo JL, Hof H, Rieken S, Kuhn S, Welzel T, Debus J, Combs SE. Single-dose radiosurgical treatment for hepatic metastases--therapeutic outcome of 138 treated lesions from a single institution. Radiat Oncol 2013;8:175. [PMID: 23837905 DOI: 10.1186/1748-717X-8-175] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
6 Bibault JE, Dewas S, Vautravers-Dewas C, Hollebecque A, Jarraya H, Lacornerie T, Lartigau E, Mirabel X. Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity. PLoS One. 2013;8:e77472. [PMID: 24147002 DOI: 10.1371/journal.pone.0077472] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 8.4] [Reference Citation Analysis]
7 Gkika E, Hawkins MA, Grosu AL, Brunner TB. The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer. Front Oncol 2020;10:604387. [PMID: 33381458 DOI: 10.3389/fonc.2020.604387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ohri N, Dawson LA, Krishnan S, Seong J, Cheng JC, Sarin SK, Kinkhabwala M, Ahmed MM, Vikram B, Coleman CN, Guha C. Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study. J Natl Cancer Inst. 2016;108. [PMID: 27377923 DOI: 10.1093/jnci/djw133] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
9 Dutta D, Krishnamoorthy S, Sudahar H, Muthukumaran M, Ramkumar T, Govindraj J. Robotic radiosurgery treatment in liver tumors: Early experience from an Indian center. South Asian J Cancer 2018;7:175-82. [PMID: 30112334 DOI: 10.4103/sajc.sajc_19_18] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Scorsetti M, Comito T, Cozzi L, Clerici E, Tozzi A, Franzese C, Navarria P, Fogliata A, Tomatis S, D'Agostino G, Iftode C, Mancosu P, Ceriani R, Torzilli G. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT). J Cancer Res Clin Oncol. 2015;141:1301-1309. [PMID: 25644863 DOI: 10.1007/s00432-015-1929-y] [Cited by in Crossref: 93] [Cited by in F6Publishing: 78] [Article Influence: 13.3] [Reference Citation Analysis]
11 Stera S, Balermpas P, Chan MKH, Huttenlocher S, Wurster S, Keller C, Imhoff D, Rades D, Dunst J, Rödel C, Hildebrandt G, Blanck O. Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis. Strahlenther Onkol 2018;194:143-55. [PMID: 28875297 DOI: 10.1007/s00066-017-1204-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
12 Ihnát P, Skácelíková E, Tesař M, Penka I. Stereotactic body radiotherapy using the CyberKnife® system in the treatment of patients with liver metastases: state of the art. Onco Targets Ther 2018;11:4685-91. [PMID: 30127616 DOI: 10.2147/OTT.S165878] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Shiozawa K, Watanabe M, Ikehara T, Matsukiyo Y, Kogame M, Kishimoto Y, Okubo Y, Makino H, Tsukamoto N, Igarashi Y, Sumino Y. Comparison of percutaneous radiofrequency ablation and CyberKnife® for initial solitary hepatocellular carcinoma: A pilot study. World J Gastroenterol 2015; 21(48): 13490-13499 [PMID: 26730160 DOI: 10.3748/wjg.v21.i48.13490] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
14 Kok END, Jansen EPM, Heeres BC, Kok NFM, Janssen T, van Werkhoven E, Sanders FRK, Ruers TJM, Nowee ME, Kuhlmann KFD. High versus low dose Stereotactic Body Radiation Therapy for hepatic metastases. Clin Transl Radiat Oncol 2020;20:45-50. [PMID: 31886419 DOI: 10.1016/j.ctro.2019.11.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Sandler KA, Veruttipong D, Agopian VG, Finn RS, Hong JC, Kaldas FM, Sadeghi S, Busuttil RW, Lee P. Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma. Adv Radiat Oncol 2016;1:237-43. [PMID: 28740893 DOI: 10.1016/j.adro.2016.10.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
16 Le Bon M, Lapeyre M, Moreau J, Bellière-Calandry A, Pezet D, Abergel A, Bellini R, Kwiatkowski F, Verrelle P, Martin F, Benoît C. [Tolerance of hypofractionated stereotactic radiotherapy for hepatic tumours]. Cancer Radiother 2019;23:385-94. [PMID: 31300328 DOI: 10.1016/j.canrad.2019.02.004] [Reference Citation Analysis]
17 Shiozawa K, Watanabe M, Ikehara T, Kobayashi K, Ochi Y, Suzuki Y, Fuchinoue K, Yoneda M, Kenmochi T, Okubo Y, Mori T, Makino H, Tsukamoto N, Igarashi Y, Sumino Y. Evaluation of contrast-enhanced ultrasonography for hepatocellular carcinoma prior to and following stereotactic body radiation therapy using the CyberKnife® system: A preliminary report. Oncol Lett 2016;11:208-12. [PMID: 26870190 DOI: 10.3892/ol.2015.3874] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
18 Tanguturi SK, Wo JY, Zhu AX, Dawson LA, Hong TS. Radiation therapy for liver tumors: ready for inclusion in guidelines? Oncologist. 2014;19:868-879. [PMID: 25001265 DOI: 10.1634/theoncologist.2014-0097] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
19 Andratschke N, Parys A, Stadtfeld S, Wurster S, Huttenlocher S, Imhoff D, Yildirim M, Rades D, Rödel CM, Dunst J, Hildebrandt G, Blanck O. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases. Radiat Oncol 2016;11:74. [PMID: 27236333 DOI: 10.1186/s13014-016-0652-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
20 Tran A, Woods K, Nguyen D, Yu VY, Niu T, Cao M, Lee P, Sheng K. Predicting liver SBRT eligibility and plan quality for VMAT and 4π plans. Radiat Oncol 2017;12:70. [PMID: 28438215 DOI: 10.1186/s13014-017-0806-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
21 Rubio C, Morera R, Hernando O, Leroy T, Lartigau SE. Extracranial stereotactic body radiotherapy. Review of main SBRT features and indications in primary tumors. Rep Pract Oncol Radiother 2013;18:387-96. [PMID: 24416584 DOI: 10.1016/j.rpor.2013.09.009] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
22 Sanuki N, Takeda A, Kunieda E. Role of stereotactic body radiation therapy for hepatocellular carcinoma. World J Gastroenterol 2014; 20(12): 3100-3111 [PMID: 24696597 DOI: 10.3748/wjg.v20.i12.3100] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
23 Zhang T, Sun J, He W, Li H, Piao J, Xu H, Duan X. Stereotactic body radiation therapy as an effective and safe treatment for small hepatocellular carcinoma. BMC Cancer 2018;18:451. [PMID: 29678159 DOI: 10.1186/s12885-018-4359-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
24 Kong M, Hong SE. Optimal follow-up duration for evaluating objective response to radiotherapy in patients with hepatocellular carcinoma: a retrospective study. Chin J Cancer 2015;34:79-85. [PMID: 25418189 DOI: 10.5732/cjc.014.10136] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
25 Guo H, Li W, Wang B, Chen N, Qian L, Cui J. Coexisting opportunities and challenges: In which scenarios can minimal/measurable residual disease play a role in advanced non-small cell lung cancer? Chin J Cancer Res 2021;33:574-82. [PMID: 34815631 DOI: 10.21147/j.issn.1000-9604.2021.05.04] [Reference Citation Analysis]
26 Hellevik T, Martinez-Zubiaurre I. Radiotherapy and the tumor stroma: the importance of dose and fractionation. Front Oncol 2014;4:1. [PMID: 24478982 DOI: 10.3389/fonc.2014.00001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 8.9] [Reference Citation Analysis]
27 Boldrini L, Romano A, Mariani S, Cusumano D, Catucci F, Placidi L, Mattiucci GC, Chiloiro G, Cellini F, Gambacorta MA, Indovina L, Valentini V. MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach. J Cancer Res Clin Oncol 2021;147:2057-68. [PMID: 33398447 DOI: 10.1007/s00432-020-03480-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Kato H, Yoshida H, Taniguch H, Nomura R, Sato K, Suzuki I, Nakata R. Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma. World J Gastroenterol 2015; 21(46): 13101-13112 [PMID: 26673627 DOI: 10.3748/wjg.v21.i46.13101] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
29 Rusthoven CG, Schefter TE. Rationale for ablation of oligometastatic disease and the role of stereotactic body radiation therapy for hepatic metastases. Hepat Oncol 2014;1:81-94. [PMID: 30190943 DOI: 10.2217/hep.13.12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
30 Keane FK, Hong TS. Role and Future Directions of External Beam Radiotherapy for Primary Liver Cancer. Cancer Control 2017;24:1073274817729242. [PMID: 28975835 DOI: 10.1177/1073274817729242] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]